Literature DB >> 74289

Minimum structural requirements for encephalitogen and for adjuvant in the induction of experimental allergic encephalomyelitis.

Y Nagai, K Akiyama, K Suzuki, S Kotani, Y Watanabe, T Shimono, T Shiba, S Kusumoto, F Ikuta, S Takeda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 74289     DOI： 10.1016/0008-8749(78)90135-1

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  7 in total

Review 1.  Muramyl peptides. Chemical structure, biological activity and mechanism of action.

Authors:  A Adam; J F Petit; P Lefrancier; E Lederer
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

Review 2.  Experimental Animal Models for Moyamoya Disease: A Species-Oriented Scoping Review.

Authors:  Lei Cao; Yang Dong; Kaiwen Sun; Dongpeng Li; Hao Wang; Hongwei Li; Bo Yang
Journal:  Front Surg       Date:  2022-07-01

3.  Peptide length requirement for experimental allergic encephalomyelitis in guinea pigs.

Authors:  S Levit; J M Powers; D Milek; S W Brostoff
Journal:  Neurochem Res       Date:  1980-01       Impact factor: 3.996

4.  Suppression of experimental allergic encephalomyelitis (EAE) with liposome-encapsulated protease inhibitor: therapy through the blood-brain barrier.

Authors:  T Osanai; Y Nagai
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

5.  Antiviral response elicited by a completely synthetic antigen with built-in adjuvanticity.

Authors:  R Arnon; M Sela; M Parant; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

6.  Chronic hypersensitivity pneumonitis produced in the rabbit by the adjuvant effect of inhaled muramyl dipeptide (MDP).

Authors:  H B Richerson; M T Suelzer; P A Swanson; J E Butler; W C Kopp; E F Rose
Journal:  Am J Pathol       Date:  1982-03       Impact factor: 4.307

7.  Induction of experimental autoimmune encephalomyelitis in Dark Agouti rats without adjuvant.

Authors:  S Stosic-Grujicic; Z Ramic; V Bumbasirevic; L Harhaji; M Mostarica-Stojkovic
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.